Description
Developer of a suite of innovative research tools designed for modification of proteins and cells and innovative cellular immunotherapies. The company's research tools will help drive fundamental new discoveries in protein structure/function and through systematic and deliberate modification of proteins, providing a platform for development of protein-based drugs with enhanced performance.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-May-2017 | Completed | Out of Business | |||
1. Early Stage VC (Series A) | 01-Jan-2014 | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Vanessa Winfield | Operations Manager | ||
Gregg Beloff JD | Chief Financial Officer | ||
Ramani Varanasi | Chief Business Officer |
Name | Representing | Role | Since |
---|---|---|---|
Hidde Ploegh Ph.D | Self | Co-Founder & Board Member | 000 0000 |